BTA
Click for more information
0.00% 57.0¢ biota holdings limited

Explains why GSK were so willing to share trial results for...

  1. PortableAlpha
    3,045 Posts.
    clock Created with Sketch.
    04/10/12
    21:05
    Post #: 10815134
    Explains why GSK were so willing to share trial results for relenza and why Roche were not so forthcoming?

    http://www.6minutes.com.au/news/latest-news/unpublished-studies-show-tamiflu-doesn-t-work
    BTA Price at posting: 73.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Drilling kicks off at Goldsworthy East—30 holes planned to unlock major westward potential
right-arrow Created with Sketch.
NEWS $25M secured to fuel growth, see which company is making big moves
right-arrow Created with Sketch.
NEWS Boorara Gold Project hits first ore milestone—$30M in free cashflow forecast, find out what’s driving the success
right-arrow Created with Sketch.
CC9 Chariot Corporation (ASX:CC9) refines Black Mountain strategy, launching Pilot Mine to seize U.S. lithium opportunity
right-arrow Created with Sketch.
NEWS Significant copper and TREO results from West Arunta Project indicate a substantial multi-million tonne copper resource, with mineralisation starting from surface
right-arrow Created with Sketch.
NEWS Drilling at May Queen intersects altered porphyritic rocks and copper sulphides, supporting a large-scale copper-gold system
right-arrow Created with Sketch.
watchlist Created with Sketch. Add BTA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.